Targeting obesity could benefit a large proportion of patients with obstructive sleep apnea (OSA). GLP-1 receptor agonist (RA)-based treatments offer a promising therapeutic approach, but the phenotypes that respond best — either alone or in combination with continuous positive airway pressure (CPAP) — still need to be identified to enable personalized care. The update was presented in 2026 at the European Respiratory Society Congress in Barcelona, Spain. mdsc.pe/3T5Ydyd

A new international consensus statement offers recommendations for general population screening of children for early-stage type 1 diabetes (T1D), starting with ensuring that the appropriate infrastructure is in place. The writing panel was convened by Breakthrough T1D and endorsed by 20 other societies, including the European Association for the Study of Diabetes, International Society of Pediatric and Adolescent Diabetes, and Association of Diabetes Care and Education Specialists, along with several other country-specific diabetes associations. The new guidance follows a previous one from the same panel published in 2024, regarding the management of people who have already been screened either independently or in family-member screening programs such as TrialNet and have tested positive for T1D-related autoantibodies. mdsc.pe/4hps4cV

Alzheimer’s disease (AD) is not contagious. It cannot be caught through touching, caring for, living with, or otherwise having routine contact with someone who has the disease. But a small and growing body of evidence suggests that, in rare circumstances, amyloid-beta pathology associated with AD — and possibly AD itself — may be transmitted from one person to another through certain medical procedures including childhood injections of cadaver-derived growth hormone (c-hGH), dura mater grafts, and reused neurosurgical instruments. What evidence supports the existence of iatrogenic AD, what remains speculative, and how should clinicians discuss the findings with concerned patients? Tap the link to read more: mdsc.pe/4rFtrc7

Managing fluid overload in patients with heart failure and chronic kidney disease requires a careful balance. Explore evidence-based strategies for outpatient diuresis, managing resistance and congestion, and integrating emerging treatment options. 🔗 mdsc.pe/4ydDWp9

Patients with chronic inflammatory dermatologic conditions face unique challenges at every stage of life. Our new Advancing Clinical Excellence page brings together curated tools, expert interviews, and case studies to help you deliver tailored, lifelong care. Explore it today! mdsc.pe/3T7eYZQ

In recent Medscape Insights reports, we've learned that a fair number of physicians are anxious about the cost of care affecting their relationships with patients. They're burned out, depressed, or both. And they're wondering what's up with the next generation of docs. But do they feel their profession is doing anything about it? For our State of the Medical Profession Index, we asked 1028 physicians across more than 29 specialties to rate their satisfaction with how the medical profession is currently handling issues such as patient face time and managing insurance companies' power, and their optimism in the profession making progress in those areas in the next 5 years. Read the full report at the link: mdsc.pe/4zixvBV

Less gadolinium with high-quality imaging? Discover how next-generation GBCAs deliver high signal intensity at lower doses. Watch our quickfire discussion with experts now: mdsc.pe/441f4E9

📅 Save the date and make sure you don’t miss #LVDlive27! Join us next year for the Las Vegas Dermatology Seminar, September 16–19, 2027. More expert insights, clinical updates, and opportunities to connect with the dermatology community. mdsc.pe/4iIxnGs

Felipe Fregni of Harvard says the real AI risk is not reduced thinking but trainees who cannot critically evaluate AI output; he outlines how medical schools should respond. mdsc.pe/4hM0urz

From telehealth and compounded drugs to marketing and financial arrangements, GLP-1 prescribing carries legal risks clinicians should know about. Healthcare attorney Ericka Adler breaks down what to watch for. Tap the link to read the full commentary: mdsc.pe/4d5Ijuh

Early studies suggest advantages in visualization, training, and workload, but questions remain about ergonomics, reliability, cost, and whether these gains improve patient care. mdsc.pe/4yQ57Xm

Influenza vaccination was associated with a 39% lower risk for hospitalization for influenza among patients with chronic obstructive pulmonary disease (COPD) during epidemic periods across six influenza seasons in England. However, vaccination was also linked to a 17% lower risk for urinary tract infection, which served as a negative control outcome with no plausible causal connection to the vaccine, suggesting that residual confounding may have biased the findings. mdsc.pe/4hmsfWj

While the stroke rate among older adults in the US declined over the past 30 years, the rate among individuals aged 20-54 years nearly doubled, largely due to an increase in ischemic strokes, a new study showed. Despite the increase in the stroke rate in this age group, there was a slight decrease in short-term mortality between 1993 and 2020, which investigators said suggests that more young adults are living with post-stroke disability. “While stroke has traditionally been considered a disease of older adults, our findings show that stroke is becoming increasingly common in younger adults,” lead investigator Emily Fisher, MD, Department of Neurology and Rehabilitation Medicine, University of Cincinnati, Cincinnati, said in a news release. mdsc.pe/4d2rfFy

Pharmacists can play a key role in increasing HPV vaccination and helping prevent HPV-related cancers. Explore best practices for immunization, strategies for addressing common misconceptions, and opportunities to improve vaccine uptake. 🔗 mdsc.pe/4ddFyHe

Deliver more personalized myasthenia gravis care by learning how lived experience, patient priorities, and emerging therapies can shape holistic treatment strategies. Explore the latest expert-led educational activity. mdsc.pe/4pLkFZ9

New research helps explain how a common virus and genetic susceptibility may work in concert to trigger multiple sclerosis (MS) attacks. An analysis of longitudinal blood samples from patients with relapsing-remitting MS revealed evidence of Epstein-Barr virus (EBV) reactivation and broad immune activation beginning weeks to months before a clinical relapse. The pre-relapse changes were particularly prominent in B-cell populations enriched for MS-associated genetic risk signals. If validated in larger, prospective studies, blood biomarkers of EBV activity could complement MRI scans and existing blood biomarkers to identify relapse risk before overt inflammatory damage is detected, researchers noted. mdsc.pe/3TMdsMU

The Diff-erence Makers: Impact of Microbiota-Based Therapies for rCDI nitter.net/i/broadcasts/1qxoNYgON…

Starting in 1 HOUR ➡️ mdsc.pe/4htDyNG Join Dr. Axelrad, Dr. Sears & Dr. Vega LIVE to explore how live biotherapeutic products are revolutionizing recurrent C. diff care! 🦠 #Gastroenterology #Cdiff #MedEd

In a 3-year analysis of the SURMOUNT-1 trial, most participants with obesity or overweight and prediabetes who reached their lowest weight on tirzepatide had regained little of it by the end of the study — 70% regained less than 5% of their baseline weight. Even with some rebound, patients retained most of their metabolic gains — suggesting a small amount of regain is not necessarily a cause for concern. mdsc.pe/4AsdiuJ

When patients with obesity aren’t reaching their health goals, what comes next? Review evidence-based approaches to therapy selection, titration, and intensification to help individualize care. 🔗 mdsc.pe/4wPQemG